OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia

OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia

Introduction: Fibromyalgia (FM) is a frequent comorbidity in patients with chronic migraine (CM). PREEMPT trials, which demonstrated the efficacy of OnabotulinumtoxinA (OnabotA) on CM, excluded patients with FM. Our aim was to evaluate the effectiveness of OnabotA in a series of patients with CM and...

Full description

Bibliographic Details
Main Authors: María Sastre Real, Javier Díaz de Terán
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Neurology
Subjects:
chronic migraine
fibromyalgia
onabotulinumtoxinA
central sensitization
comorbidities
quality of life
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.575130/full

Similar Items

Similar Items